Top Markets
Coin of the day
N4 Pharma Plc N4 Pharma Plc

N4 Pharma Plc

N4P
Rangering i aksjer #20665
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica... N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Aksjekurs
$0.00646333
Markedsverdi
$53.79K
Endring (1 dag)
0.00%
Endring (1 år)
4.94%
Land
GB
Handel N4 Pharma Plc (N4P)

Kategori

P/S-forhold for N4 Pharma Plc (N4P)
P/S-forhold per March 2026 TTM: 559.49
Ifølge N4 Pharma Plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 559.49. Ved slutten av 2023 hadde selskapet et P/S-forhold på 1.06K.
P/S-historikk for N4 Pharma Plc fra 2000 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 559.49 127.99%
2024 245.40 -76.79%
2023 1.06K 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 1.97 0.00%
2015 0.00 -100.00%
2014 0.98 -5.70%
2013 1.03 16.79%
2012 0.89 -0.76%
2011 0.89 -65.53%
2010 2.59 48.86%
2009 1.74 8.39%
2008 1.61 40.15%
2007 1.15 -10.62%
2006 1.28 -58.60%
2005 3.10 34.01%
2004 2.31 21.21%
2003 1.91 100.32%
2002 0.95 -3.68%
2001 0.99 -25.00%
2000 1.32 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
2.22 -99.60%
DE
3.43 -99.39%
FR
2.01 -99.64%
JP
5.38 -99.04%
US
3.03 -99.46%
GB